Best Recombinant Proteins CDMOs in United States

← All Recombinant Proteins CDMOs Best Clean FDA History Commercial Scale

Region: USA Europe Asia

CDMOs tracked

Fully scored

With FDA records

FDA inspections

EMA/MHRA GMP certs

For US-manufactured recombinant proteins programs, Pharmaron Biologics, KBI Biopharma, and Wacker Biotech lead CDMO Signal's ranking of recombinant proteins CDMOs with confirmed US facilities. Filtered from the global directory of 14 scored recombinant proteins CDMOs to 9 with US manufacturing presence. US-based manufacturing carries specific advantages for sponsors filing under FDA jurisdiction: FDA inspection records — which form the core of the Signal Score's Quality Compliance pillar — apply directly, and QP release complexity common to EU-manufactured material does not apply. Rankings update as new inspection and certificate data enters the platform. Full methodology at cdmosignal.com/methodology.

Recombinant protein CDMOs make therapeutic proteins, enzymes, and growth factors using microbial (E. coli, yeast) or mammalian (CHO) expression. Choice of host turns on post-translational modification needs, scale economics, and downstream-purification complexity.

Selecting a recombinant protein CDMO turns on host-system experience, validated bioreactor scale, downstream purification and analytics, and a clean regulatory record. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 4 NAI (no action), 4 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: Denmark (18), Germany (13), United States (8), Lithuania (8), Netherlands (3).

Last updated 2026-08-01. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

#	CDMO	Signal Score	Quality	FDA · GMP	Capacity	Programs
1	PB Pharmaron Biologics San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China	86.9	100.0	3 insp · 0 GMP	Available	0 programs
2	KB KBI Biopharma Durham, NC · Boulder, CO	83.5	100.0	1 insp · 1 GMP	Limited	0 programs
3	WK Wacker Biotech Jena, DE · Amsterdam, NL · San Diego, CA	81.6	100.0	0 insp · 13 GMP	—	0 programs
4	NW Northway Biotech Vilnius, LT; Waltham (MA), USA	80.8	100.0	0 insp · 8 GMP	Available	0 programs
5	AG AGC Biologics Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP	80.6	99.9	2 insp · 23 GMP	Available	2 programs
6	CA Catalent (Novo Holdings) Harmans, MD · Gosselies, BE	75.1	79.3	1 insp · 0 GMP	Available	0 programs
7	LZ Lonza Biologics Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH	72.8	95.1	1 insp · 0 GMP	Limited	0 programs
8	Cytovance Biologics Oklahoma City, OK	61.5	—	—	Available	0 programs
9	BN Bionova Scientific Fremont, CA	59.0	—	—	—	0 programs
—	Advanced BioScience Laboratories, Inc. (ABL Inc.) Rockville, MD	Profiled	—	—	—	0 programs
—	Scorpius BioManufacturing San Diego, CA	Profiled	—	—	—	0 programs
—	iBio (FastPharming / iBio CDMO LLC) Bryan, TX (historic CDMO facility); current corporate pivot to San Diego, CA	Profiled	—	—	—	0 programs
—	Kentucky Bioprocessing (KBP) Owensboro, KY	Profiled	—	—	—	0 programs
—	Wheeler Bio Oklahoma City, OK	Profiled	—	—	—	0 programs

How we score CDMOs →

What to evaluate in a Recombinant Proteins CDMO

Expression host & scale

Microbial hosts (E. coli, P. pastoris) suit non-glycosylated proteins; mammalian (CHO) is the workhorse for glycoproteins. Confirm validated bioreactor scale and the CDMO's experience with your target.

Purification & analytics

Downstream complexity (multiple chromatography steps, refolding for E. coli) drives cost and timeline. Ask about the orthogonal analytics package — purity, identity, potency.

Regulatory readiness

Clean FDA 483 history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.

Capacity & commercial readiness

For programs heading to BLA, evaluate validated commercial scale and any approved-product track record.

FDA jurisdiction — how the ranking scores US-based CDMOs

The Signal Score's Quality Compliance pillar (35% of the composite) is dominated by FDA inspection data for US-based CDMOs: Establishment Inspection Report classifications (NAI, VAI, OAI), Form 483 observation counts, and Warning Letter history. For a CDMO whose primary facility footprint is US, this pillar carries direct weight — an inspection on the site slated for a sponsor's program applies without translation. For CDMOs with mixed US + international facility footprint, the ranking reflects the composite regulatory posture; sponsors evaluating for a specific program should verify inspection history on the exact US site under consideration via that CDMO's profile page.

Which US CDMOs also cover EU and UK regulatory geographies?

Many top-tier US-based CDMOs maintain EU (EMA) and UK (MHRA) GMP certification for facilities used to supply EU and UK trials or commercial markets. The Signal Score's Quality Compliance pillar includes EMA + MHRA certificate density as a component — a US-headquartered CDMO with dense EU/UK certificates typically ranks higher on this pillar than a US-only competitor. Sponsors running dual-jurisdiction programs should cross-check the individual CDMO profile pages for specific certificate coverage; the Europe region ranking surfaces CDMOs that also appear in the European jurisdiction ranking, indicating multi-region regulatory posture.

How CDMO Signal identifies US manufacturing presence

Region attribution is derived from each CDMO's declared facility locations in our directory. A CDMO's facility list is validated against corporate filings, press releases, and — where public — the FDA facility registration (FEI number lookups). Region matching is done at the country level: a US state name or two-letter abbreviation in the facility list places the CDMO in the US region. CDMOs with US + international sites appear in every applicable region ranking, which reflects operational reality — such a CDMO is a legitimate candidate for programs in any of those jurisdictions.

Recombinant Proteins CDMOs — Frequently Asked Questions

Who are the top Recombinant Proteins CDMOs?

By CDMO Signal's independent Signal Score, the top-ranked Recombinant Proteins CDMOs include Pharmaron Biologics, KBI Biopharma, Wacker Biotech. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.

How many Recombinant Proteins CDMOs have FDA inspection records?

CDMO Signal tracks 5 Recombinant Proteins CDMOs with FDA inspection records and 45 EMA/MHRA GMP certificates across the group.

What should I look for in a recombinant protein CDMO?

Confirm expression-host experience for your target (microbial vs mammalian), validated bioreactor scale, a strong downstream-purification platform, qualified analytics, and a clean FDA and EMA/MHRA record.

How is a recombinant protein CDMO different from a mAb CDMO?

There's significant overlap — mAbs are recombinant proteins. But mAb CDMOs are typically optimized for CHO-based platform processes, while general recombinant protein CDMOs handle a wider range of hosts and non-mAb formats (enzymes, growth factors, complex non-glycoproteins).

Related modalities

Biologics / mAb CDMOs mRNA / LNP CDMOs Cell Therapy CDMOs

Other Modalities

AAV CAR-T Lentiviral Cell Therapy mRNA/LNP Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome ADC